Lantern Pharma Inc. (LTRN) stock
LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.02 (-6.17%)
Close on Nov 17, 2026Market cap $4.67MP/E –Yield –
Lantern Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lantern Pharma's enterprise value was -$1.22M on Nov 11, 2026, against $27.60M a year earlier. Over the last 5 years it ranged from -$20.99M to $53.04M, with a median of $7.53M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.22M | -105.8% |
| 2025 | Dec 31, 2025 | $21.09M | +232.1% |
| 2024 | Dec 31, 2024 | $6.35M | +298.4% |
| 2023 | Dec 29, 2023 | $1.59M | -79.4% |
| 2022 | Dec 30, 2022 | $7.75M | -49.8% |
| 2021 | Dec 31, 2021 | $15.44M | -84.4% |
| 2020 | Dec 31, 2020 | $98.89M | – |
See a number that looks wrong?